Top Markets
Coin of the day
Wuhan General Group (China), Inc. Wuhan General Group (China), Inc.

Wuhan General Group (China), Inc.

WUHN
Clasificación en acciones #41554
Wuhan General Group (China), Inc. is a nutraceutical biotechnology company,... Wuhan General Group (China), Inc. is a nutraceutical biotechnology company, which engages in the development of alternative plant-based cannabinoids and psilocybin medical research that commercializes a range of cannabidiol and mushrooms-based products under the Dr. AnnaRx, Medspresso and Handcrafted Delights brands. The firm is also engages in research and development of indications for psilocybin new therapies that will help patients who suffer from mental illness, Alzheimer's and Parkinson's. The company was founded by Xu Jie and Jeff Robinson on July 19, 1988 and is headquartered in Cape Town, South Africa.
Precio por acción
$0.0003
Última sincronización: 2026-08-11
Capitalización bursátil
$16.55K
Cambio (1 día)
0.00%
Cambio (1 año)
200.00%
País
ZA
Comercio Wuhan General Group (China), Inc. (WUHN)

Categoría

Ratio P/S de Wuhan General Group (China), Inc. (WUHN)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Wuhan General Group (China), Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Wuhan General Group (China), Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras